COVID-19 AND YOUR EMPLOYMENT RIGHTS

by admin | Apr 22, 2024 | Article

While the global coronavirus pandemic escalates. it’s understandable that many employees are nervous about heading into work every day – particularly those with lupus or other autoimmune conditions. Employers have a positive obligation to take reasonable care to...

Lupus Canada hosted a Facebook Live Q&A with Dr. Matsos on Tuesday, March 31. Dr. Matsos answered questions specific to COVID-19 and its impact on lupus.

by admin | Apr 22, 2024 | Video

The Canadian Rheumatology Association has released their position statement on COVID-19 and Hydroxychloroquine Supply

by admin | Apr 22, 2024 | Article

Canadian Rheumatology Association Position Statement on COVID-19 and Hydroxychloroquine Supply The Canadian Rheumatology Association (CRA) is committed to supporting its members in their efforts to continue to deliver optimal care for their patients with rheumatic...

Canadian lupus patients missing critical drug after claims it treats coronavirus.

by admin | Apr 22, 2024 | Article

Canadian lupus patients missing critical drug after claims it treats coronavirus. To read the full story visit https://globalnews.ca/news/6761222/hydroxychloroquine-lupus-coronavirus-drug

“Hydroxychloroquine has long been a standard treatment for lupus and rheumatoid arthritis patients.

by admin | Apr 22, 2024 | Article

“Hydroxychloroquine has long been a standard treatment for lupus and rheumatoid arthritis patients. But many of them have reported having trouble obtaining it, said Leanne Mielczarek, executive director of Lupus Canada. ‘They are experiencing difficulty,’ she said....